417 related articles for article (PubMed ID: 9603321)
1. Interaction and co-encapsidation of human immunodeficiency virus type 1 Gag and Vif recombinant proteins.
Huvent I; Hong SS; Fournier C; Gay B; Tournier J; Carrière C; Courcoul M; Vigne R; Spire B; Boulanger P
J Gen Virol; 1998 May; 79 ( Pt 5)():1069-81. PubMed ID: 9603321
[TBL] [Abstract][Full Text] [Related]
2. Interaction of human immunodeficiency virus type 1 Vif with Gag and Gag-Pol precursors: co-encapsidation and interference with viral protease-mediated Gag processing.
Bardy M; Gay B; Pébernard S; Chazal N; Courcoul M; Vigne R; Decroly E; Boulanger P
J Gen Virol; 2001 Nov; 82(Pt 11):2719-2733. PubMed ID: 11602784
[TBL] [Abstract][Full Text] [Related]
3. Vif is largely absent from human immunodeficiency virus type 1 mature virions and associates mainly with viral particles containing unprocessed gag.
Sova P; Volsky DJ; Wang L; Chao W
J Virol; 2001 Jun; 75(12):5504-17. PubMed ID: 11356958
[TBL] [Abstract][Full Text] [Related]
4. Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor.
Bouyac M; Courcoul M; Bertoia G; Baudat Y; Gabuzda D; Blanc D; Chazal N; Boulanger P; Sire J; Vigne R; Spire B
J Virol; 1997 Dec; 71(12):9358-65. PubMed ID: 9371595
[TBL] [Abstract][Full Text] [Related]
5. Sequence requirements for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 Gag precursor into retrovirus-like particles.
Carrière C; Gay B; Chazal N; Morin N; Boulanger P
J Virol; 1995 Apr; 69(4):2366-77. PubMed ID: 7884882
[TBL] [Abstract][Full Text] [Related]
6. Effects of nucleocapsid mutations on human immunodeficiency virus assembly and RNA encapsidation.
Zhang Y; Barklis E
J Virol; 1997 Sep; 71(9):6765-76. PubMed ID: 9261401
[TBL] [Abstract][Full Text] [Related]
7. The inhibition of assembly of HIV-1 virus-like particles by 3-O-(3',3'-dimethylsuccinyl) betulinic acid (DSB) is counteracted by Vif and requires its Zinc-binding domain.
Dafonseca S; Coric P; Gay B; Hong SS; Bouaziz S; Boulanger P
Virol J; 2008 Dec; 5():162. PubMed ID: 19105849
[TBL] [Abstract][Full Text] [Related]
8. Assembly and extracellular release of chimeric HIV-1 Pr55gag retrovirus-like particles.
Wagner R; Deml L; Fliessbach H; Wanner G; Wolf H
Virology; 1994 Apr; 200(1):162-75. PubMed ID: 7510434
[TBL] [Abstract][Full Text] [Related]
9. Human immunodeficiency virus type 1 MA deletion mutants expressed in baculovirus-infected cells: cis and trans effects on the Gag precursor assembly pathway.
Chazal N; Gay B; Carrière C; Tournier J; Boulanger P
J Virol; 1995 Jan; 69(1):365-75. PubMed ID: 7983731
[TBL] [Abstract][Full Text] [Related]
10. Incorporation of Vpr into human immunodeficiency virus type 1: role of conserved regions within the P6 domain of Pr55gag.
Checroune F; Yao XJ; Göttlinger HG; Bergeron D; Cohen EA
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):1-7. PubMed ID: 7648278
[TBL] [Abstract][Full Text] [Related]
11. The I domain is required for efficient plasma membrane binding of human immunodeficiency virus type 1 Pr55Gag.
Sandefur S; Varthakavi V; Spearman P
J Virol; 1998 Apr; 72(4):2723-32. PubMed ID: 9525590
[TBL] [Abstract][Full Text] [Related]
12. Human immunodeficiency virus type 1 Vif protein is an integral component of an mRNP complex of viral RNA and could be involved in the viral RNA folding and packaging process.
Zhang H; Pomerantz RJ; Dornadula G; Sun Y
J Virol; 2000 Sep; 74(18):8252-61. PubMed ID: 10954522
[TBL] [Abstract][Full Text] [Related]
13. trans-acting proteins involved in RNA encapsidation and viral assembly in human immunodeficiency virus type 1.
Kaye JF; Lever AM
J Virol; 1996 Feb; 70(2):880-6. PubMed ID: 8551627
[TBL] [Abstract][Full Text] [Related]
14. Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells.
Chazal N; Carrière C; Gay B; Boulanger P
J Virol; 1994 Jan; 68(1):111-22. PubMed ID: 8254720
[TBL] [Abstract][Full Text] [Related]
15. Specific packaging of APOBEC3G into HIV-1 virions is mediated by the nucleocapsid domain of the gag polyprotein precursor.
Schäfer A; Bogerd HP; Cullen BR
Virology; 2004 Oct; 328(2):163-8. PubMed ID: 15464836
[TBL] [Abstract][Full Text] [Related]
16. Mapping and characterization of the N-terminal I domain of human immunodeficiency virus type 1 Pr55(Gag).
Sandefur S; Smith RM; Varthakavi V; Spearman P
J Virol; 2000 Aug; 74(16):7238-49. PubMed ID: 10906178
[TBL] [Abstract][Full Text] [Related]
17. Single point mutations in the zinc finger motifs of the human immunodeficiency virus type 1 nucleocapsid alter RNA binding specificities of the gag protein and enhance packaging and infectivity.
Mark-Danieli M; Laham N; Kenan-Eichler M; Castiel A; Melamed D; Landau M; Bouvier NM; Evans MJ; Bacharach E
J Virol; 2005 Jun; 79(12):7756-67. PubMed ID: 15919928
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the assembly function of the human immunodeficiency virus type 1 gag protein nucleocapsid domain.
Zhang Y; Qian H; Love Z; Barklis E
J Virol; 1998 Mar; 72(3):1782-9. PubMed ID: 9499028
[TBL] [Abstract][Full Text] [Related]
19. Gag-Gag interactions in the C-terminal domain of human immunodeficiency virus type 1 p24 capsid antigen are essential for Gag particle assembly.
Zhang WH; Hockley DJ; Nermut MV; Morikawa Y; Jones IM
J Gen Virol; 1996 Apr; 77 ( Pt 4)():743-51. PubMed ID: 8627263
[TBL] [Abstract][Full Text] [Related]
20. Development of HIV/AIDS vaccine using chimeric gag-env virus-like particles.
Kang CY; Luo L; Wainberg MA; Li Y
Biol Chem; 1999 Mar; 380(3):353-64. PubMed ID: 10223338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
